🇺🇸 FDA
Patent

US 7279469

Diaminotriazoles useful as inhibitors of protein kinases

granted A61PA61P1/16A61P11/06

Quick answer

US patent 7279469 (Diaminotriazoles useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P1/16, A61P11/06, A61P13/12, A61P15/00